HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Fragrance allergens

This article was originally published in The Rose Sheet

Executive Summary

EU unlikely to require general warning statement "can cause allergic reaction" on fragrance labeling following an Oct. 5 meeting of the European Commission's Committee on Adaptation to Technical Progress. EU member states felt the caveat "would not add anything to the important information and may even be potentially misleading," Colipa says. Instead, the Cosmetic Directive amendment probably will require only ingredient labeling of 24 known fragrance allergens. The draft is expected to be released in November and voted on in December. A vote on the proposal had been planned for Oct. 5, but was postponed due to technical errors in the text (1"The Rose Sheet" Sept. 25, In Brief)

Latest Headlines
See All
UsernamePublicRestriction

Register

RS008553

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel